How
Many People Have Cancer Patients (Alive or Deceased)
in Their Homes, in Our City?
.........................................................................................................................
Dilek Toprak1, Nurhan Dogan2, Serap Demir3, Gülnihal
Tufan3
1. Afyon Kocatepe University, Department of
Family Medicine, Turkey,
2. Afyon Kocatepe University, Department of
Biostatistics, Turkey,
3. Afyon Kocatepe University, Department of
Internal Medicine, Turkey
Corresspondence to:
Dilek Toprak, MD
Department of Family Medicine
Afyon Kocatepe University,
Afyonkarahisar 03200, TURKEY
Telephone number : 0090 532 3827836
Fax number : 0090 272 2132907
E-mail : dilekt66@yahoo.com
|
ABSTRACT
Objectives:
Our aim was to assess how many people
have cancer (alive or deceased) in their
homes, in our city; the types of cancer,
and their relationship with living places
and economic status.
Methods:
A questionnaire was administered to 2035
people in 75 different parts of our city.
Only one person in each house was selected
and asked if there had been any cancer
patients living or deceased in the house.
Results:
There were 100 (4.9%) people who have
been living with a patient diagnosed as
having cancer and 333 people (16.4%) who
had a history of a patient who had died
from cancer in the home. The death rate
among 333 patients was 34.2% for lung
cancer, 9.0% for gastric cancer and 7.21%
for colon cancer. Also people living in
urban areas have more living (odds ratio=1.45)
and deceased (odds ratio=1.28) cancer
patients in their homes, than people living
in villages.
Conclusion:
Cancer is a part of our lives either with
a patient in our house or a relative who
has died from cancer. So public education
and health services for homecare need
for many people to care for these cancer
patients. According to our study lung
cancer is the most prevalent cancer in
our region.
Key words:
Cancer, prevalence, family, Turkey, epidemiology.
|
Cancer is a serious growing problem worldwide,
especially a disease of the developing world.
It is not only a biological processes it is
also the outcome of lifestyle decisions and
social conditions. So we need to understand
what causes cancer at the biological and social
levels but also what cancer causes to the families,
to the people living with a person who has cancer.
Based on the World Cancer Report there were
10.1 million new cases, 6.2 million deaths and
22.4 million persons living with cancer in the
year 2000. It is second to cardiovascular disease
as a cause of death in developed countries and
the number of new cases is expected to grow
by 50% over the next 20 years, to reach 15 million
by 2020(1). In 2006, in Europe, there
were an estimated 3,191,600 cancer cases diagnosed
(excluding non-melanoma skin cancers) and 1,703,000
deaths from cancer(2). Cancer is
an important problem in both public health and
political terms worldwide, irrespective of a
country's development.
Cancer arises out of conditions of life, which
result in exposure to carcinogens.We can argue
about two factors on this subject:
- Changes people make in the world
- Where people live
We know that there are social factors in cancer
etiology, which include socioeconomic status,
occupation (industrial hazards), radiation,
medications, habits, food handling, air and
water pollution.
These social dimensions of cancer have important
implications for the design of cancer control
programming. They stem from behavior patterns
that people evolve to meet their biological,
psychological and social needs. These patterns,
in turn, create a lifestyle which influences
cancer incidence. They include the development
of addictions to tobacco, drugs and alcohol,
the ways in which food is prepared, stored and
eaten, and certain other risk patterns.
The disease is widely feared around the world
over as synonymous with suffering and death.
Patients may be stigmatized and experience social
isolation and family tensions as well as the
inability to get insurance or even job loss
with economic dependence aggravated by high
costs of medical care, if there is no health
insurance. This condition also causes changes
in lifestyle of the families involved.
As a result cancer impacts not only on the
patient, but also his or her family and community.
The aim of our study was to assess how many
people have cancer patients (living or deceased)
in their homes, in our city; the types of cancers,
and their relationship with living places and
economic status.
The study was conducted in Afyonkarahisar,
a middle Anatolian city, between November 2005
and February 2006. The present study was approved
by the Afyon Kocatepe University Faculty of
Medicine Clinical Research Ethics Committee
and written, informed consent was obtained from
all participants.
A total of 2035 people, from 75 different screening
regions (18 urban, 57 villages) of our city
were detected according to the population records
of the year 2000, which represent the population
of the area appropriately. A total of 7000 km.
roadway driven for the research by a team of
15 physicians, 1 nurse and a driver. The records
of the regional health institutions were used
in order to determine the subjects. People older
than 18 years old were grouped as 19-40 years
old, 41-64 years old, 65 and over. According
to population distribution of year 2000, we
determined the minimum number of people as 1990
(when d=0.02) and at the end of the study we
reached a number of 2035 people. The study group
selected randomly from the "Family Cards"
of the primary health centers, regarding the
gender and ages. Only one person was selected
from every house.
The subjects were informed about the study
by telephone interviews one night before, their
approvals were obtained and their transport
to the health institutions, where the study
would be conducted, was provided. The data were
collected by a questionnaire in which face to
face survey method was performed by the physicians.
As this study is a part of a big epidemiological
research study only the question about cancer
(Is there a person with cancer or who has died
from cancer) was regarded and its relations
with economic status and living place have been
evaluated. Also type of cancer was asked about.
The data of the study was written in SPSS 12.0
version. Statistical evaluation of the study
was performed using the chi-square test and
p values lower than 0.05 were accepted as significant.
We found that there were 333 (16.4%) people
who had a history of a patient who had died
from cancer in their home and 100 (4.9%) people
living together with a cancer patient. So in
total, 19.71% (n=401) of our study group were
living or/and had lived before with cancer patients
in their homes. Also people living in urban
areas have more living (odds ratio=1.45) and
deceased (odds ratio=1.28) cancer patients in
their homes than people living in villages.
According to economic status; 75.2% of total
study group had low income, which was similar
(76.81%) in cancer patients' families. The distribution
of these people regarding the living place and
economic status has been shown in Table 1 and
2.
| Table
1 Distribution
of cancer cases (living, dead and total)
according to living places |
|
|
Cancer (living) |
Cancer (dead) |
Cancer (total) |
|
Yes No |
Yes No |
Yes No |
|
Urban
n
%
|
63 1044
(5.7) (94.3)
|
198 909
(17.9) (82.1)
|
237 870
(21.4) (78.6)
|
Village
n
%
|
37 891
(4.0) (96.0)
|
135 793
(14.5) (85.5)
|
164 764
(17.7) (82.3)
|
|
Total |
100 1935
(4.9) (95.1)
|
333 1702
(16.4) (83.6)
|
401 1634
(19.7) (80.3)
|
| |
X2 = 3.13
p= 0.077
|
X2 = 4.112
p= 0.043
|
X2 = 4.45
p= 0.035
|
| Table
2 Economic
status of cancer cases' families |
| |
Cancer(alive) |
Cancer(dead) |
Cancer(total) |
|
Low
Medium-High
|
67 (67%)
33 (33%)
|
260 (78.08%)
73 (21.92%)
|
308 (76.81%)
93 (23.19%)
|
|
Total |
100 (100%) |
333 (100%) |
401 (100%) |
The most common cancer types among 333 dead
cancer patients was lung cancer (n=114, 34.2%),
stomach cancer (n=30, 9.0%), colon cancer (n=24,
7.21%), larynx (n=22, 6.61%) and leukemia/ lymphoma
(n=21, 6.31%) respectively. Gender distribution
of the first 5 common cancer types, among 333
died cancer patients is shown in Table 3.
| Table
3 Gender
distribution of the first 5 common cancer
types, among 333 dead cancer patients |
| |
Female
n % |
Male
n % |
Total
n (% in 333) |
|
Lung cancer |
15 13.2 |
99 86.8 |
114 34.2% |
|
Stomach cancer |
11 36.7 |
19 63.3 |
30 9.0% |
|
Colon cancer |
9 37.5 |
15 62.5 |
24 7.21% |
|
Larynx cancer |
1 4.5 |
21 95.5 |
22 6.61% |
|
Leukemia/lymphoma |
7 33.3 |
14 66.7 |
21 6.31% |
The living cancer patients were mostly suffering
from lung cancer (n=18, 18.0%) of which 83.3%
(n=13) were men, larynx cancer (n=13, 13.0%),
breast cancer (n=13, 13.0%), prostate cancer
(n=9, 9.0%) and leukemia/ lymphoma (n=9, 9.0%)
respectively. Gender distribution of the first
5 common cancer types, among 100 living cancer
patients is shown in Table 4. Also the gender
distribution of both living and dead cancer
patients are listed in Table 5.
| Table
4 Gender
distribution of the first 5 common cancer
types, among 100 living cancer patients |
| |
Female
n % |
Male
n % |
Total
n |
|
Lung cancer |
3 16.7 |
15 83.3 |
18 |
|
Larynx cancer |
5 38.5 |
8 61.5 |
13 |
|
Breast cancer |
13 100 |
0 0 |
13 |
|
Prostate cancer |
0 0 |
9 100 |
9 |
|
Leukemia/lymphoma |
3 33.3 |
6 66.7 |
9 |
| Table
5 Gender
distribution cancer (alive and dead) patients |
| |
Cancer (alive) |
Cancer (dead) |
|
Female
Male
|
48 (48%)
52 (52%)
|
104 (31.2%)
229 (68.8%)
|
|
Total |
100 (100%) |
333 (100%) |
Regarding all the study group (n=2035) the
most prevalent cancers were lung cancer (n=132,
6.49%), gastric cancer (n=37, 1.82%), larynx
cancer (n=35,1.72%), colon cancer (n=30, 1.47%),
leukemia/ lymphoma (n=30, 1.47%) and breast
cancer (n=29, 1.43%), respectively.
In our study we founda total 19.71% (n=401)
families who were affected by cancer, either
living with a cancer patient and/or cancer death.
This result also approximately showed the cancer
rate of our city, which meant one of five families
is affected by a type of cancer. As it is mentioned
in WHO's World Cancer Report; worldwide, twelve
percent of people die from cancer and in industrialized
countries more than one in four will die from
the disease which means each of us will experience
grief and pain as a result of cancer, as a patient,
a family member or a friend (1). In a study
by Boyle et al it has found that one in four
to one in five North Americans will die of cancer
and in countries with a westernised lifestyle
about half of all deaths are caused by circulatory
disease and a quarter by cancer(3).
In this study, we found lung cancer as the
most common cancer type causing death and it
is also the most prevalent cancer in our region.
Lung cancer as the most common death causing
cancer, is similar with many other studies,
but the total number of cases changes according
to the country. In American Cancer Society reports,
the most common cancer deaths in both genders
has seen lung cancer numbers decline but it
is the second highest level of cancer cases(4).
In 2007, the most common form of cancer was
breast cancer (429,900 cases, 13.5% of all cancer
cases), followed by colorectal cancers (412,900,
12.9%) and lung cancer (386,300, 12.1%); while
in 2004, lung cancer was the most common cancer
in Europe, followed by colorectal cancer (13.2%)
and breast cancer (13%)(5,6).
In another study in Portugal the most frequent
cancer among men in 2000 was cancer of the colorectum
followed by cancers of the prostate, lung, stomach
and urinary bladder. In women, breast cancer
was the most common cancer followed by cancers
of the colorectum, stomach and corpus uteri(7).
According to our study the probable reason
of high prevalence of lung cancer in men is
high smoking rates in our population, which
is directly related with lung cancer. In a study
in our region the smoking prevalence (including
ex-smokers) is 36%; which is 74.4% in men and
8.7% in women(8). In a report by
the Turkish Minister of Health it is indicated
that the most common cancer in our country is
lung cancer (17.6%) and it was guessed that
30,000 - 40,000 people die from lung cancer
every year(9). Regarding a study
in Turkey, the smoking prevalence among 15 and
over aged population is 43% (63% in men, 24%
in women), which is really a big danger for
lung cancer(10). We can confirm the
increasing trend of lung cancer as there is
an increase in smoking among women. Lung cancer
and several other forms of cancer, could be
diminished by improved tobacco control. Also
the lung cancer rates were particularly high
in much of Eastern Europe reflecting current
and past tobacco smoking habits of many of its
inhabitants(6). By widespread use
of screening tests, carrying out big projections
about controlling cancer can lower the rates.
This kind of study can reduce the traumatic
effects of cancer on the families who are mostly
responsible for the care of cancer patients.
In many countries all over the world among
women, breast cancer is the most prevalent cancer
like our results(4,6,11,12). But
we have to pay attention to lung cancer in women
also because of increasing smoking prevalence
in our country.
Cancer causes 1/20 of deaths in developing
countries and ¼ of all deaths in developed
countries. This means it is the second commonest
cause of death after cardiovascular disease.
Thus most individuals in the world have some
experience of the disease, if not personally,
then in a family member, friend or acquaintance.
Cancer remains an important public health problem
also in Turkey, and we think the ageing of our
population and high smoking prevalence will
cause these cancer numbers to continue to increase.
Thus regarding our results many individuals
in our region have some experience of cancer
whether suffering themself from cancer or a
cancer patient in their home. We think this
brings a social health expectation of education
about homecare of cancer patients. At the present
time, neither the government nor the private
sector properly provide reimbursement for homecare
in Turkey or there are only limited numbers
of homecare services which are only in big cities
and given by private health services. In most
of the regions, families and the patients have
serious health promotion gaps. Relatives try
to provide care at home to those people with
cancer. None of the hospitals are providing
home care in an organized or official way. We,
as health staff, have to pay attention to this
subject and help the families and make big projects
about homecare of cancer patients.
The education of the relatives or the caregivers
of cancer patients is so important and can probably
be done by a family physician who is responsible
for the social, psychological and biological
health of the members and the family. In a study
by Jones LE et al, it is shown that primary
care utilization in the early phase of cancer
treatment has a marked effect that results in
a reduced mortality risk in patients with incident
lung cancer(13). In another study
by McAvoy BR et al among 210 organisations 42%
provided cancer education and training. As a
result of good adult education practice 95%
of organisations ran accredited programs(14).
So with funding support and well-structured
organizations primary care professionals can
play a critical role in cancer care.
The primary caregivers' evaluation of caring
for a terminally ill patient at home in conjunction
with a home palliative care service were both
high and positive(15). The National
Strategy Document for Cancer in the Republic
of Ireland proposes that cancer treatment services
should be centered around primary care services,
regional services and supra-regional centers(16).
Like tobacco prevention (especially focused
on the male population), diet and physical activity
(risk factors for colorectal cancer) concerning
should be the main subjects of family educations
by primary care servers.
The next stage of our study can be the social
and psychological affects of living with cancer
patients on the families; the effect of education
and giving information services to families
about cancer.
- Bernard W. Stewart, Paul Kleihues. World
Cancer Report World Heath Organisation, International
Agency for Research on Cancer page 11-21.
- Ferlay J, Autier P, Boniol M, Heanue M,
Colombet M, Boyle P. Estimates of the cancer
incidence and mortality in Europe in 2006.
Ann Oncol 2007 Mar;18(3):581-92. Epub 2007
Feb.
- Peter Boyle, J S Langman., "ABC of
colorectal cancer" BMJ 2000;321:805-808
(30 September)
- American Cancer Society 2007. Accessed
on Jan 2007, http://www.cancer.org/downloads/STT/313,4,2007
Estimated US Cancer Deaths.
- P. Boyle and J. Ferlay. Cancer incidence
and mortality in Europe, 2004. Annals of Oncology
2005;16(3):481-488.
- Bray F, Sankila R, Ferlay J, Parkin DM.
Estimates of cancer incidence and mortality
in Europe in 1995. Eur J Cancer 2002 Jan;38(1):99-166.
- P. S. Pinheiro, J. E. Tyczyski, F. Bray,
J. Amado, E. Matos and D. M. Parkin. Cancer
incidence and mortality in Portugal European
Journal of Cancer Volume 39, Issue 17, November
2003, Pages 2507-2520.
- Sozbilir H, Cekirdekci A, Toprak D. Afyonkarahisar
ili Saglik Taramasi (Health Controls in Afyonkarahisar).
Uyum Ajans, Ankara, 2006. In Turkish.
- Kokturk N, Ozturk C, Kirisoglu CE. Sigara
ve Akciger Kanseri. Solunum 2003;5:139-45.
- Anon. Public research report on cigarette
addiction and anti-cigarette campaign. PIAR
Jan 1988;In Turkish.
- AIRT Working Group. Italian cancer figures--report
2006: 1. Incidence, mortality and estimates
Epidemiol Prev. 2006 Jan-Feb;30(1 Suppl 2):8-10,
12-28, 30-101.
- Bhurgri Y, Bhurgri A, Pervez S, Bhurgri
M, Kayani N, Ahmed R, Usman A, Hasan SH. Cancer
profile of Hyderabad, Pakistan 1998-2002.
Asian Pac J Cancer Prev 2005 Oct-Dec;6(4):474-80.
- Jones LE, Doebbeling CC. Beyond the traditional
prognostic indicators: the impact of primary
care utilization on cancer survival. J Clin
Oncol 2007 Dec 20;25(36):5793-9.
- McAvoy BR, Fletcher JM, Elwood M. Cancer
education and training in primary health care--a
national audit of training providers. Aust
Fam Physician 2007 Nov;36(11):973-6.
- Sano T, Maeyama E, Kawa M, Shirai Y, Miyashita
M, Kazuma K, Okabe T. Family caregiver's experiences
in caring for a patient with terminal cancer
at home in Japan. Palliat Support Care 2007
Dec;5(4):389-95.
- Johnston PG, Daly PA, Liu E. The NCI All
Ireland Cancer Conference. Oncologist 1999;4(4):275-277.
|